Drug Control News

CDSCO Surveillance Drive Reveals Just 2 Percent of Drug Samples Substandard


NEW DELHI: A special nationwide drive by the Central Drug Standards Control Organization (CDSCO) to check the quality of drugs from manufacturing plants has found that just a little over two per cent of the drug samples were of not-standard quality. However, not a single case of spurious drug came to light during the drive.


The CDSCO collected as many as 1,710 drug samples from the manufacturing sites located at various manufacturing hub / clusters / locations falling under the jurisdiction of CDSCO zonal and sub-zonal offices under the special drive launched in December 2012. Out of the total samples, 1,123 were tested at its drug testing laboratories and only 26 were found to be of not-standard quality.


The North Zone collected 229 samples, out of which 219 were tested and seven were found of sub-standard quality. The West Zone collected 290 samples, out of which 161 were tested and seven were found of sub-standard quality, while the South Zone reported no cases of substandard quality after collecting 278 samples and testing 112 of them. A total of 73 samples were lifted from the east zone and only 27 were sent for testing, out of which only one sample did not conform to the standards. Similarly, two samples each from Bangalore, Ahmedabad and Chandigarh which fall under sub-zonal offices were found to be substandard from 296, 61 and 147 samples, respectively.


After the special drive, the CDSCO directed the concerned State Drug Controllers to stop further distribution of the substandard drugs in the market and to initiate necessary action against the manufacturers under the Drugs and Cosmetics Act, 1940.

 

Beside, joint surprise raids with the state drug controllers were carried out by the CDSCO at various government hospitals, wholesale dealers & retail shops and samples were drawn with different pharmacological categories. This move was intended to check the quality of drugs on monthly basis from April 2013. In this move, 706 samples were collected from nine different states, out of which 306 were tested and 35 were found to be of not-standard quality. Jammu and Kashmir witnessed 27 cases of not-standard quality drugs from 156 tested. In Himachal Pradesh, 121 samples were taken and 97 of them were tested, out of which seven turned out to be of not-standard quality. Checks were also held in Madhya Pradesh (June), Assam and Meghalaya (July), Bihar (August), Uttar Pradesh (September), Uttarakhand (October), Odisha (November) and Rajasthan (December) by the teams from the CDSCO and the State authorities. In this case also the same directive has been given by the CDSCO to the state drug controllers.

 

 

 

 

Subscription